Richard Roden
Johns Hopkins University
H-index: 81
North America-United States
Top articles of Richard Roden
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Phase II Trial Assessing Safety, Efficacy and Immune Correlates of Heterologous Prime-Boost with pBI-11 (IM) and TA-HPV (IM) Plus Pembrolizumab for Advanced, PD-L1 CPS≥ 1 … | International Journal of Radiation Oncology, Biology, Physics | Michael Gibson P Savvides F Worden R Gopalakrishnan T Wu | 2024/4/1 |
Editor's Note: Delivery of Telomerase Reverse Transcriptase Small Interfering RNA in Complex with Positively Charged Single-Walled Carbon Nanotubes Suppresses Tumor Growth | Clinical Cancer Research | Zhuohan Zhang Xiaoying Yang Yuan Zhang Bin Zeng Shujing Wang | 2024/2/16 |
Virus-like particle vaccine displaying an external, membrane adjacent MUC16 epitope elicits ovarian cancer-reactive antibodies | Journal of Ovarian Research | Hsin-Fang Tu Margaret Wong Ssu-Hsueh Tseng Nattha Ingavat Pola Olczak | 2024/1/16 |
Profiling of VEGF Receptors and Immune Checkpoints in Recurrent Respiratory Papillomatosis | The Laryngoscope | Brandon Lam Jonas Miller Yu Jui Kung TC Wu Chien‐Fu Hung | 2024/1/9 |
Development and anticancer properties of Up284, a spirocyclic candidate ADRM1/RPN13 inhibitor | Plos one | Ravi K Anchoori Vidyasagar Anchoori Brandon Lam Ssu-Hsueh Tseng Samarjit Das | 2023/6/14 |
Immune responses, therapeutic anti-tumor effects, and tolerability upon therapeutic HPV16/18 E6/E7 DNA vaccination via needle-free biojector | Mbio | Shiwen Peng Hsin-Fang Tu Michelle Cheng Ming-Hung Hu Hua-Ling Tsai | 2023/10/31 |
Safety run-in of intramuscular pNGVL4a-Sig/E7 (detox)/HSP70 DNA and TA-CIN protein vaccination as treatment for HPV16+ ASC-US, ASC-H, or LSIL/CIN1 | Cancer Prevention Research | Mark H Einstein Richard BS Roden Louise Ferrall Mark Akin Allison Blomer | 2023/4/3 |
Vaccination with an HPV therapeutic vaccine (TA-CIN) in patients with HPV16 associated cervical cancer yields robust immunologic responses: Differential effects by vaccination … | Gynecologic Oncology | Stephanie Gaillard Jade Alvarez Hao Wang Hua-Ling Tsai Amy Deery | 2023/9/1 |
Small molecule rpn13 inhibitors with antitumor properties | 2023/2/9 | ||
Mus musculus papillomavirus 1 E8^ E2 represses expression of late protein E4 in basal-like keratinocytes via NCoR/SMRT-HDAC3 co-repressor complexes to enable wart formation in vivo | Mbio | Franziska Kuehner Margaret Wong Elke Straub John Doorbar Thomas Iftner | 2023/8/31 |
Anti-cancer spirocyclic-guanidine compounds and uses thereof | 2023/8/3 | ||
Cross-neutralizing protection of vaginal and oral mucosa from HPV challenge by vaccination in a mouse model | Vaccine | Chelsea Sanders Rebecca L Matthews Sayyed Hamid Zarkesh Esfahani Nazneen Khan Nimit L Patel | 2023/7/12 |
677 Phase II trial assessing safety, efficacy and immune correlates of heterologous prime-boost with pBI-11 (IM) and TA-HPV (IM) plus pembrolizumab for advanced, PD-L1 CPS≥ 1 … | Michael K Gibson Panayiotis Savvides Francis Worden Ellen Heimann-Nichols TC Wu | 2023/11/1 | |
Erratum for Peng et al.,“Development of a Spontaneous HPV16 E6/E7-Expressing Head and Neck Squamous Cell Carcinoma in HLA-A2 Transgenic Mice” | Mbio | Shiwen Peng Deyin Xing Louise Ferrall Ya-Chea Tsai Richard BS Roden | 2022/4/26 |
Development of a spontaneous HPV16 E6/E7-expressing head and neck squamous cell carcinoma in HLA-A2 transgenic mice | MBio | Shiwen Peng Deyin Xing Louise Ferrall Ya-Chea Tsai Richard BS Roden | 2022/2/22 |
Vaccination with human alphapapillomavirus-derived L2 multimer protects against human betapapillomavirus challenge, including in epidermodysplasia verruciformis model mice | Virology | Pola Olczak Margaret Wong Hua-Ling Tsai Hao Wang Reinhard Kirnbauer | 2022/10/1 |
Safety and feasibility of an HPV therapeutic vaccine (TA-CIN) in patients with HPV16 associated cervical cancer (458) | Gynecologic Oncology | Stephanie Gaillard Amy Deery Amanda Nickles Fader Warner Huh Margaret Liang | 2022/8/1 |
RG2-VLP: a vaccine designed to broadly protect against anogenital and skin human papillomaviruses causing human cancer | Journal of virology | Pola Olczak Ken Matsui Margaret Wong Jade Alvarez Paul Lambert | 2022/7/13 |
PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model | Cancer Immunology, Immunotherapy | Shiwen Peng Marietta Tan Yen-Der Li Max A Cheng Emily Farmer | 2021/4 |
Cervical cancer immunotherapy: facts and hopes | Louise Ferrall Ken Y Lin Richard BS Roden Chien-Fu Hung T-C Wu | 2021/9/15 |
Co-Authors
